000			05903nam a2200361 c 4500
988			_aSpringer_BiomedLife_2019
999			_c115566 _d115566 _x1
001			115566
003			ESmaUEC
005			20230110040236.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			190617s2019 gw a o |||| 0|eng d
020			_a9783642277726
024	7		_a10.1007/978-3-642-27772-6 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM315 _b2019 EB
245	0	0	_aEncyclopedia of Psychopharmacology _cedited by Ian P. Stolerman, Lawrence H. Price.
264		1	_aBerlin _bSpringer International Publishing _c2019
300			_a1 recurso en línea (XLVI, 690 páginas) _b 206 ilustraciones, 80 ilustraciones a color
336			_aTexto _btxt _2rdacontent
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aBiomedical and Life Sciences (Springer-11642)
505	0		_aFrom the Contents: ABC Transporters -- Absorption -- Abstinence -- Abuse -- Abuse Liability -- Acamprosate -- BAC -- Balanced Placebo Design -- Barbital -- Barbiturates -- Basal Forebrain Cholinergic Neurons -- Behavioral Allocation Function -- Cabergoline -- Cachexia -- Caffeine -- Caffeine Withdrawal Syndrome -- Caffeinism -- cAMP -- DARPP-32 -- db/db Mouse -- D-cycloserine -- Decision Making -- Declarative and Non-Declarative Memory -- Declarative Memory -- Early Ventral Hippocampal Lesion Model -- Eating and Appetite -- Eating Disorder: Anorexia Nervosa -- Eating Disorders: Animal Models -- Eating Disorders: Binge-Eating -- Echolalia -- FAA -- Face Validity -- Facial Dysmorphology -- False Memory -- False Negative -- False Positive -- G protein-Coupled Receptors -- GABA -- GABAA Receptor -- GABAergic Transmission -- Gabapentin -- Galantamine -- Habit Reversal Therapy -- Habit Reversal Training -- Habituation -- Half-Life -- Hallucinations -- Hallucinogen Abuse -- IACUC -- ICD -- Idiopathic -- Imaging Mass Spectrometry -- Imipramine -- Impairment of Functioning; Measurement Scales -- Kappa-Opioid Agonists -- Kappa-Receptor -- Keratotic Lesion -- Ketamine -- Ketamine -- Khat -- L-Alpha-Acetyl-Methadol -- Lamotrigine -- Lanreotide -- Latent Inhibition -- Latin Square Design -- Laxatives -- Magnetic Resonance Imaging -- Major and Minor and Mixed Anxiety-Depressive Disorders -- Major Tranquilizer -- Mania -- MAO-B Inhibitor -- Mass Spectrometry -- N-Acetylcysteine -- Nafion -- Naloxone -- Naltrexone -- N-Arachidonylethanolamine -- Narcolepsy -- ob/ob Mouse -- Obsessions -- Obsessive-Compulsive Anxiety Disorders -- Occasion Setting with Drugs -- Octreotide -- Off-Label Use of Drugs -- P300 -- Pain -- Pain and Psychopharmacology -- Pair-Feeding -- Palatability -- Paliperidone -- qEEG -- QT Interval -- Quality of Life -- Quazepam -- Quetiapine -- Radial Arm Maze -- Radionuclide -- Radiopharmaceutical -- Radiotracer -- Randomized Controlled Trials -- Rapamycin -- Saporin -- Satiety -- Saturation Binding Curve -- Scalar Property -- Schedule I -- Schedule II -- Tachykinins -- Tachyphylaxis -- Tandospirone -- Tardive Dyskinesia -- Taste Reactivity Test -- Temazepam -- Ubiquitin-Proteasome System -- Ultrasonic -- Ultrasonic Vocalizations -- Ultrasonic Vocalizations -- Unblocking -- Unconditional Response -- Vaccination -- Vaccines and Drug-Specific Antibodies -- Vagus Nerve Stimulation -- Valproic Acid -- Values-Based Medicine -- Varenicline -- Wakefulness -- Water Maze -- Whole-Cell Recording -- Wisconsin Card Sorting Test -- Wisconsin General Test Apparatus -- Withdrawal Syndromes -- Yale-Brown Obsessive-Compulsive Scale -- Yohimbine -- Zaleplon -- Zero-Order Elimination Kinetics -- Ziprasidone -- Zolpidem -- Zonisamide -- Zopiclone.
520	3		_aPsychopharmacology is the study of the effects of psychoactive drugs on the functioning of the central nervous system at all levels of analysis, thus embracing cognition, behaviour, psychological states, neurophysiology, neurochemistry, gene expression and molecular biology. It includes, as an integral part of its domain, the interaction of environmental and genetic factors with psychoactive drug action, their medicinal and social uses, and their abuse. The Encyclopedia of Psychopharmacology provides detailed information on psychopharmacology and its sub-disciplines, such as clinical psychopharmacology, molecular neuropsychopharmacology, behavioural pharmacology in laboratory animals, preclinical psychopharmacology, human experimental psychopharmacology. The wide-ranging entries in the Encyclopedia of Psychopharmacology are written by leading experts. They will provide basic and clinical scientists in academia as well as industry with valuable information about the field of psychopharmacology. Also people in related fields, students, teachers, and interested laypeople will benefit from the important and relevant information on the most recent developments of psychopharmacology. Entries will fall into several main categories: Methods, techniques and target systems (explaining nature of a technique and its uses and limitations) - Drugs and classes of drug (mainly describing effects and mechanisms of action) - Psychiatric states (explaining drugs used to treat them) - Miscellaneous currently interesting topics that do not fall within the above (e.g. cognitive enhancement, regulation and licensing, substance use in religious rituals).
650		7	_2embne _9139882 _aPsicofarmacología
700	1		_aStolerman, Ian P _eeditor _4http://id.loc.gov/vocabulary/relators/edt _994020
700	1		_aPrice, Lawrence H _eeditor _4http://id.loc.gov/vocabulary/relators/edt _994021
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-642-27772-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_aSI _cm _dz _feng _ggw _h0 _b12/2019 _ek _zSI